Cargando…

Risk factors and pharmacotherapy for chemotherapy-induced peripheral neuropathy in paclitaxel-treated female cancer survivors: A retrospective study in Japan

Chemotherapy-induced peripheral neuropathy (CIPN) is a dose-limiting adverse reaction in cancer patients treated with several cytotoxic anticancer agents including paclitaxel. Duloxetine, an antidepressant known as a serotonin-noradrenalin reuptake inhibitor, is the only agent that has moderate evid...

Descripción completa

Detalles Bibliográficos
Autores principales:	Hiramoto, Shiori, Asano, Hajime, Miyamoto, Tomoyoshi, Takegami, Manabu, Kawabata, Atsufumi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8719717/ https://www.ncbi.nlm.nih.gov/pubmed/34972132 http://dx.doi.org/10.1371/journal.pone.0261473

Ejemplares similares

Role of HMGB1 in Chemotherapy-Induced Peripheral Neuropathy
por: Sekiguchi, Fumiko, et al.
Publicado: (2020)

Chemotherapy-induced peripheral neuropathy: part 1—current state of knowledge and perspectives for pharmacotherapy
por: Sałat, Kinga
Publicado: (2020)

Perturbations in neuroinflammatory pathways are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors
por: Miaskowski, Christine, et al.
Publicado: (2019)

Development of diabetes mellitus following hormone therapy in prostate cancer patients is associated with early progression to castration resistance
por: Hayashi, Tomonori, et al.
Publicado: (2021)

Pathomechanisms of Paclitaxel-Induced Peripheral Neuropathy
por: Klein, Ines, et al.
Publicado: (2021)

Caspase-Dependent HMGB1 Release from Macrophages Participates in Peripheral Neuropathy Caused by Bortezomib, a Proteasome-Inhibiting Chemotherapeutic Agent, in Mice
por: Tsubota, Maho, et al.
Publicado: (2021)

Expression of mitochondrial dysfunction-related genes and pathways in paclitaxel-induced peripheral neuropathy in breast cancer survivors
por: Kober, Kord M, et al.
Publicado: (2018)

Skin Extracellular Matrix Breakdown Following Paclitaxel Therapy in Patients with Chemotherapy-Induced Peripheral Neuropathy
por: Staff, Nathan P., et al.
Publicado: (2023)

The effectiveness of regional cooling for paclitaxel-induced peripheral neuropathy
por: Sato, Junya, et al.
Publicado: (2016)

2043: Pharmacokinetic prediction of paclitaxel-induced peripheral neuropathy
por: Hertz, Daniel L., et al.
Publicado: (2018)

Whole-Body Vibration as a Modality for the Rehabilitation of Peripheral Neuropathies: Implications for Cancer Survivors Suffering from Chemotherapy-Induced Peripheral Neuropathy
por: Verhulst, Anna L.J., et al.
Publicado: (2015)

Development and validation of the comprehensive assessment scale for chemotherapy–induced peripheral neuropathy in survivors of cancer
por: Kanda, K., et al.
Publicado: (2019)

Chemotherapy‐induced peripheral neuropathy increases nontraumatic fracture risk in breast cancer survivors
por: McNeish, Brendan L., et al.
Publicado: (2021)

Peripheral Neuropathy Caused by Paclitaxel and Docetaxel: An Evaluation and Comparison of Symptoms
por: Tofthagen*, Cindy, et al.
Publicado: (2013)

Chemotherapy-induced peripheral neuropathy
por: Zhang, Xia, et al.
Publicado: (2017)

Survey of the management of chemotherapy-induced peripheral neuropathy in Japan: Japanese Society of Medical Oncology
por: Hirayama, Yasuo, et al.
Publicado: (2016)

Risk Factors for Chemotherapy-Induced Peripheral Neuropathy Caused by Nanoparticle Albumin-Bound Paclitaxel in Advanced Breast Cancer
por: Guo, Qie, et al.
Publicado: (2022)

Neurofilament light as a predictive biomarker of unresolved chemotherapy-induced peripheral neuropathy in subjects receiving paclitaxel and carboplatin
por: Burgess, B. L., et al.
Publicado: (2022)

Yoga for cancer survivors with chemotherapy‐induced peripheral neuropathy: Health‐related quality of life outcomes
por: Zhi, W. Iris, et al.
Publicado: (2021)

Effect of certain trimethoxy flavones on paclitaxel - induced peripheral neuropathy in mice
por: Nadipelly, Jagan, et al.
Publicado: (2018)

Risk factors for paclitaxel-induced peripheral neuropathy in patients with breast cancer
por: Ghoreishi, Zohreh, et al.
Publicado: (2018)

Minoxidil is a potential neuroprotective drug for paclitaxel-induced peripheral neuropathy
por: Chen, Yi-Fan, et al.
Publicado: (2017)

Losartan attenuates neuroinflammation and neuropathic pain in paclitaxel‐induced peripheral neuropathy
por: Kalynovska, Nataliia, et al.
Publicado: (2020)

A Fenofibrate Diet Prevents Paclitaxel-Induced Peripheral Neuropathy in Mice
por: Caillaud, Martial, et al.
Publicado: (2020)

Preclinical and Clinical Evidence of Therapeutic Agents for Paclitaxel-Induced Peripheral Neuropathy
por: Kawashiri, Takehiro, et al.
Publicado: (2021)

Discovery of Potential Neuroprotective Agents against Paclitaxel-Induced Peripheral Neuropathy
por: Chen, Yi-Fan, et al.
Publicado: (2022)

Duloxetine prevents bortezomib and paclitaxel large-fiber chemotherapy-induced peripheral neuropathy (LF-CIPN) in sprague dawley rats
por: Mansooralavi, Niloufar, et al.
Publicado: (2023)

Emotional Responses to Persistent Chemotherapy-induced Peripheral Neuropathy Experienced by Patients with Colorectal Cancer in Japan
por: Kanda, Kiyoko, et al.
Publicado: (2017)

Chemotherapy‐induced peripheral neuropathy in African American cancer survivors: Risk factors and quality of life outcomes
por: Trendowski, Matthew R., et al.
Publicado: (2021)

Macrophage as a Peripheral Pain Regulator
por: Domoto, Risa, et al.
Publicado: (2021)

Pathophysiology of Chemotherapy-Induced Peripheral Neuropathy
por: Starobova, Hana, et al.
Publicado: (2017)

Mechanisms of Chemotherapy-Induced Peripheral Neuropathy
por: Zajączkowska, Renata, et al.
Publicado: (2019)

Colorectal Cancer Survivors Suffering From Sensory Chemotherapy-Induced Peripheral Neuropathy Are Not a Homogenous Group: Secondary Analysis of Patients’ Profiles With Oxaliplatin-Induced Peripheral Neuropathy
por: Kerckhove, Nicolas, et al.
Publicado: (2021)

Differential methylation and expression of genes in the hypoxia-inducible factor 1 signaling pathway are associated with paclitaxel-induced peripheral neuropathy in breast cancer survivors and with preclinical models of chemotherapy-induced neuropathic pain
por: Kober, Kord M, et al.
Publicado: (2020)

Signaling pathways and gene co-expression modules associated with cytoskeleton and axon morphology in breast cancer survivors with chronic paclitaxel-induced peripheral neuropathy
por: Kober, Kord M, et al.
Publicado: (2019)

Is CT-based body composition associated with long-term chemotherapy-induced peripheral neuropathy in colorectal cancer survivors?
por: Smit, Debbie, et al.
Publicado: (2022)

A fruit fly model for studying paclitaxel-induced peripheral neuropathy and hyperalgesia
por: Hamoudi, Zina, et al.
Publicado: (2018)

Acupuncture for Paclitaxel-Induced Peripheral Neuropathy: A Review of Clinical and Basic Studies
por: Zhao, Yu-Xue, et al.
Publicado: (2021)

Acupuncture for the Management of Chemotherapy-Induced Peripheral Neuropathy
por: Visovsky, Constance
Publicado: (2012)

Chemotherapy-Induced Peripheral Neuropathy and Changes in Cytoskeleton
por: Malacrida, Alessio, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_rg2b1ej9ab1lodkeo11eb4ict4